Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NONE | Common Stock | Award | $0 | +3.05K | +16.88% | $0.00 | 21.1K | Apr 1, 2022 | Direct | F1 |
transaction | NONE | Common Stock | Award | $0 | +11.1K | +52.66% | $0.00 | 32.2K | Oct 1, 2022 | Direct | F2 |
Id | Content |
---|---|
F1 | The valuation, compensation and affiliate transactions committee and the board of directors, following the approval of the revised compensation program for independent directors, approved the issuance to each independent member of the board of directors of an additional equity award under the Equity Plan on April 1, 2022 that vested on October 1, 2022, representing the difference in value between such director's October 1, 2021 equity award and $80,000, calculated based on the NAV per share on April 1, 2022, and prorated for the remaining days between April 1, 2022 and September 30, 2022. |
F2 | On October 1, 2022, as part of the annual retainers paid to the Issuer's independent directors and pursuant to the Issuer's 2022 Equity Incentive Plan, Mr. Duncan was granted 11,111.111 shares of the Issuer's restricted common stock. The shares of restricted common stock will vest on October 1, 2023. |